Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-97.20M
↓ 94% below average
Average (6y)
$-50.17M
Historical baseline
Range
High:$-3.71M
Low:$-101.06M
CAGR
+67.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-97.20M | +3.8% |
| 2023 | $-101.06M | -37.3% |
| 2022 | $-73.61M | -64.8% |
| 2021 | $-44.67M | -69.0% |
| 2020 | $-26.43M | -611.9% |
| 2019 | $-3.71M | +17.2% |
| 2018 | $-4.48M | - |